These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 8375130)

  • 1. Central analgesic effects of desipramine, fluvoxamine, and moclobemide after single oral dosing: a study in healthy volunteers.
    Coquoz D; Porchet HC; Dayer P
    Clin Pharmacol Ther; 1993 Sep; 54(3):339-44. PubMed ID: 8375130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Central analgesic effects of antidepressant drugs with various mechanisms of action: desipramine, fluvoxamine and moclobemide].
    Coquoz D; Porchet HC; Dayer P
    Schweiz Med Wochenschr; 1991 Dec; 121(49):1843-5. PubMed ID: 1754870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous inhibition of catechol-O-methyltransferase and monoamine oxidase A: effects on hemodynamics and catecholamine metabolism in healthy volunteers.
    Illi A; Sundberg S; Ojala-Karlsson P; Scheinin M; Gordin A
    Clin Pharmacol Ther; 1996 Apr; 59(4):450-7. PubMed ID: 8612391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of moclobemide on psychomotor performance and cognitive function.
    Fairweather DB; Kerr JS; Hindmarch I
    Int Clin Psychopharmacol; 1993; 8(1):43-7. PubMed ID: 8473720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study.
    Escher M; Daali Y; Chabert J; Hopfgartner G; Dayer P; Desmeules J
    Clin Ther; 2007 Aug; 29(8):1620-31. PubMed ID: 17919544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluvoxamine drastically increases concentrations and effects of tizanidine: a potentially hazardous interaction.
    Granfors MT; Backman JT; Neuvonen M; Ahonen J; Neuvonen PJ
    Clin Pharmacol Ther; 2004 Apr; 75(4):331-41. PubMed ID: 15060511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of fluvoxamine on the pharmacokinetics of imipramine and desipramine in healthy subjects.
    Spina E; Pollicino AM; Avenoso A; Campo GM; Perucca E; Caputi AP
    Ther Drug Monit; 1993 Jun; 15(3):243-6. PubMed ID: 8333005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The advent of a new generation of monoamine oxidase inhibitor antidepressants: pharmacologic studies with moclobemide and brofaromine.
    Lavian G; Finberg JP; Youdim MB
    Clin Neuropharmacol; 1993; 16 Suppl 2():S1-7. PubMed ID: 8313392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of acute fluvoxamine and desipramine administration on melatonin and cortisol production in humans.
    Skene DJ; Bojkowski CJ; Arendt J
    Br J Clin Pharmacol; 1994 Feb; 37(2):181-6. PubMed ID: 8186063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moclobemide. A review of its pharmacological properties and therapeutic use in depressive illness.
    Fitton A; Faulds D; Goa KL
    Drugs; 1992 Apr; 43(4):561-96. PubMed ID: 1377119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of fluvoxamine on the pharmacokinetics of roflumilast and roflumilast N-oxide.
    von Richter O; Lahu G; Huennemeyer A; Herzog R; Zech K; Hermann R
    Clin Pharmacokinet; 2007; 46(7):613-22. PubMed ID: 17596106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluvoxamine in the treatment of tricyclic-resistant depression.
    White K; Wykoff W; Tynes LL; Schneider L; Zemansky M
    Psychiatr J Univ Ott; 1990 Sep; 15(3):156-8. PubMed ID: 2123039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of neuropharmacologic selectivity in antidepressant action: fluvoxamine versus desipramine.
    Nathan RS; Perel JM; Pollock BG; Kupfer DJ
    J Clin Psychiatry; 1990 Sep; 51(9):367-72. PubMed ID: 2120201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluvoxamine-induced alterations in plasma concentrations of imipramine and desipramine in depressed patients.
    Spina E; Pollicino AM; Avenoso A; Campo GM; Caputi AP
    Int J Clin Pharmacol Res; 1993; 13(3):167-71. PubMed ID: 8225700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of reboxetine and desipramine on the kinetics of the pupillary light reflex.
    Theofilopoulos N; McDade G; Szabadi E; Bradshaw CM
    Br J Clin Pharmacol; 1995 Mar; 39(3):251-5. PubMed ID: 7619664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reinforcement magnitude modulation of rate-dependent effects of fluvoxamine and desipramine in the rat.
    Ginsburg BC; Lamb RJ
    Behav Pharmacol; 2008 Dec; 19(8):829-35. PubMed ID: 19020418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant-like effect of tramadol and its enantiomers in reserpinized mice: comparative study with desipramine, fluvoxamine, venlafaxine and opiates.
    Rojas-Corrales MO; Berrocoso E; Gibert-Rahola J; Micó JA
    J Psychopharmacol; 2004 Sep; 18(3):404-11. PubMed ID: 15358985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the effects of fluvoxamine and amitriptyline on autonomic functions in healthy volunteers.
    Flett SR; Szabadi E; Bradshaw CM
    Eur J Clin Pharmacol; 1992; 42(5):529-33. PubMed ID: 1606999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of fluvoxamine and erythromycin on the pharmacokinetics of oral lidocaine.
    Isohanni MH; Neuvonen PJ; Olkkola KT
    Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):168-72. PubMed ID: 16918719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of moclobemide after single and multiple oral dosing with 150 milligrams 3 times daily for 15 days.
    Guentert TW; Tucker G; Korn A; Pfefen JP; Haefelfinger P; Schoerlin MP
    Acta Psychiatr Scand Suppl; 1990; 360():91-3. PubMed ID: 2248087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.